- Vallexa Advisors

Selling Your Hospice in 2026: What the Crackdown Means for Valuation, Exit & Buyer Demand

Federal regulators just suspended Medicare payments to 447 hospices and 23 home health organizations over $600M+ in alleged fraudulent billing. For clean hospice owners weighing a sale, this is the strongest seller’s market in five years — but only if your books, compliance file, and process are ready. Here’s what your hospice is worth in 2026, how the buyer landscape has shifted, and the 7-step confidential sale process Vallexa Advisors runs for every hospice client.

2026 hospice and home health valuation multiples report showing EBITDA trends across the U.S. market

2026 Hospice & Home Health Valuation Multiples Report (US Market)

A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.

Chart showing key drivers that impact hospice EBITDA multiples, including compliance risk, earnings quality, and referral concentration.

Hospice Multiples in the Current Market: EBITDA Valuation Benchmarks, Methods, and What Drives the Multiple

Learn how hospice EBITDA multiples are set in today’s market—what drives the multiple, how compliance affects value, and how owners can prepare to maximize price.

Hospice M&A rebounds with strongest quarter since 2021, highlighting hospice valuation trends and buyer demand for quality agencies

Hospice M&A Rebounds: What the “Strongest Quarter Since 2021” Means for Hospice Owners Considering a Sale

Hospice M&A surged in late 2025, marking the strongest quarter since 2021. Learn what this means for hospice valuation, buyer demand, and selling strategy.

Top questions to ask an advisor before getting a hospice valuation and preparing to sell

What the New CMS Rules Mean for Home Health Providers — And How They Impact Your Agency’s Valuation in 2026 & Beyond

Home health and hospice owners are facing major CMS changes—from the new Team Model to MedPAC’s proposed 7% payment cut. These shifts directly influence valuation, buyer appetite, and the timing of your exit. Learn how these rules affect what your agency is worth, what buyers look for now, and how to protect your value before selling.

Vallexa Advisors helping buyers and sellers navigate home health and hospice mergers and acquisitions with a global healthcare focus

Sell or Buy a Home Health Care Business: Your 2026 Guide

Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether you’re selling a hospice, home health, or senior-care business, our team helps you navigate the complexities of valuation, compliance, and buyer negotiations — ensuring you achieve maximum value for your legacy.

Professional Vallexa Advisors banner showcasing global healthcare M&A expertise with a blue networked globe symbolizing connection, trust, and growth.

Hospice Valuation amid Fraud Crackdowns, Shutdowns & Policy Shifts: What Owners Need to Know

Digital illustration of healthcare professionals analyzing hospice valuation data and compliance metrics, representing Vallexa Advisors’ 2026 guide to hospice valuation under the HOPE Tool and Final Rule.

How the 2026 Final Rule and HOPE Tool Shape Hospice Valuation

The 2026 Final Rule and HOPE Tool are reshaping how hospice valuations are calculated. Learn how quality metrics, compliance, and data transparency affect your agency’s value — and how Vallexa Advisors helps owners navigate the changing market.

Illustration showing healthcare professionals and hospice valuation metrics, representing Vallexa Advisors’ expert guide on maximizing hospice agency value.

Hospice Valuation: Understanding the Process and Maximizing Your Agency’s Worth

Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice owners secure premium valuations through expert guidance, national reach, and success-only fees.

Vallexa Advisors

Leaders in Healthcare Mergers & Acquisitions

Tag: hospice valuation